NL
Norwalk Leslie V Director
OFFICER F
US US · SEC (Form 4)
Browse the complete record of transactions filed by Norwalk Leslie V, Director. Director active across 6 companies, notably Neurocrine Biosciences INC. In total, 16 reports have been logged. Total volume traded: €1m. The latest transaction was filed on 14 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 16 total
€120,541 1,447 shares @ €83.3042 0.0001% mcap 100.0% of flow
Common Stock
SEC:0000064803-26-000070 · 14 May 2026
€120,541 1,447 shares @ €83.3042 0.0001% mcap 50.0% of flow
Common Stock
SEC:0000064803-26-000070:0 · 14 May 2026
US$503,263 3,810 shares @ US$132.09 0.0035% mcap 100.0% of flow
Common Stock
SEC:0001533568-26-000003 · 12 May 2026
€503,263 3,810 shares @ €132.09 0.0035% mcap 50.0% of flow
Common Stock
SEC:0001533568-26-000003:0 · 12 May 2026
01,547 shares 0
Common Stock
SEC:0001209191-22-033199:0 · 1 Jun 2022
€28,223 381.005 shares @ €74.0764 0.0001% mcap 100.0% of flow
Common Stock
SEC:0001071739-22-000147:0 · 31 Mar 2022
01,100 shares 0
Common Stock
SEC:0001071739-22-000057 · 7 Feb 2022
01,223 shares 0
Common Stock
SEC:0001437749-22-002923 · 7 Feb 2022
01,100 shares 0
Common Stock
SEC:0001071739-22-000057:0 · 7 Feb 2022
01,223 shares 0
Common Stock
SEC:0001437749-22-002923:0 · 7 Feb 2022
05,698 shares 0
Ordinary Common Stock, $0.01 par value
SEC:0001209191-22-001002 · 4 Jan 2022
05,698 shares 0
Ordinary Common Stock, $0.01 par value
SEC:0001209191-22-001002:0 · 4 Jan 2022
0789 shares 0
Ordinary Common Stock, $0.01 par value
SEC:0001209191-21-051410 · 13 Aug 2021
0789 shares 0
Ordinary Common Stock, $0.01 par value
SEC:0001209191-21-051410:0 · 13 Aug 2021
01,548 shares 0
Common Stock
SEC:0001209191-21-037851 · 1 Jun 2021
01,548 shares 0
Common Stock
SEC:0001209191-21-037851:0 · 1 Jun 2021
About Norwalk Leslie V Leslie V Norwalk is a director at NEUROCRINE BIOSCIENCES INC.